BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 7529712)

  • 1. Pathways involved in muscarinic M1 and M2 receptor stimulation in rabbit vas deferens.
    Eltze M
    Eur J Pharmacol; 1994 Sep; 263(1-2):31-7. PubMed ID: 7529712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of extracellular calcium concentration on potency of muscarinic agonists at M1 and M2 receptors in rabbit vas deferens.
    Dörje F; Rettenmayr NM; Mutschler E; Lambrecht G
    Eur J Pharmacol; 1991 Oct; 203(3):417-20. PubMed ID: 1723047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of selectivity of muscarinic antagonists for M1 and M2 receptors in rabbit isolated vas deferens.
    Eltze M
    Pharmacology; 1988; 37 Suppl 1():40-7. PubMed ID: 2467317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of field stimulation-induced contractions of rabbit vas deferens by muscarinic receptor agonists: selectivity of McN-A-343 for M1 receptors.
    Davies RH; Scholes HE; Virdi S; Broadley KJ
    J Pharm Pharmacol; 2001 Apr; 53(4):487-96. PubMed ID: 11341365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Muscarinic M1 receptor agonist actions of muscarinic receptor agonists in rabbit vas deferens.
    Shannon HE; Sawyer BD; Bemis KG; Bymaster FP; Health I; Mitch CH; Ward JS
    Eur J Pharmacol; 1993 Feb; 232(1):47-57. PubMed ID: 8458395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Muscarinic M1- and M2-receptors mediating opposite effects on neuromuscular transmission in rabbit vas deferens.
    Eltze M
    Eur J Pharmacol; 1988 Jul; 151(2):205-21. PubMed ID: 2844551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of the muscarinic receptor subtype mediating inhibition of the neurogenic contractions in rabbit isolated vas deferens by a series of polymethylene tetra-amines.
    Budriesi R; Cacciaguerra S; Toro RD; Bolognesi ML; Chiarini A; Minarini A; Rosini M; Spampinato S; Tumiatti V; Melchiorre C
    Br J Pharmacol; 2001 Mar; 132(5):1009-16. PubMed ID: 11226131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of the prejunctional muscarinic receptors mediating inhibition of evoked release of endogenous noradrenaline in rabbit isolated vas deferens.
    Grimm U; Fuder H; Moser U; Bümert HG; Mutschler E; Lambrecht G
    Naunyn Schmiedebergs Arch Pharmacol; 1994 Jan; 349(1):1-10. PubMed ID: 8139696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Presynaptic muscarinic receptors mediating inhibition of neurogenic contractions in rabbit vas deferens are of the ganglionic M1-type.
    Eltz M; Gmelin G; Wess J; Strohmann C; Tacke R; Mutschler E; Lambrecht G
    Eur J Pharmacol; 1988 Dec; 158(3):233-42. PubMed ID: 2472963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional determination of McN-A-343 affinity for M1 muscarinic receptors.
    Micheletti R; Schiavone A
    J Pharmacol Exp Ther; 1990 Apr; 253(1):310-4. PubMed ID: 1691785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 4-DAMP analogues reveal heterogeneity of M1 muscarinic receptors.
    Micheletti R; Giudici L; Turconi M; Donetti A
    Br J Pharmacol; 1990 Jul; 100(3):395-7. PubMed ID: 1697193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective inhibition of responses to carbachol and McN-A-343 in the rabbit vas deferens.
    Choo LK; Mitchelson F
    Clin Exp Pharmacol Physiol; 1990 Sep; 17(9):601-11. PubMed ID: 1703935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological basis for functional selectivity of partial muscarinic receptor agonists.
    Heldman E; Barg J; Fisher A; Levy R; Pittel Z; Zimlichman R; Kushnir M; Vogel Z
    Eur J Pharmacol; 1996 Feb; 297(3):283-91. PubMed ID: 8666061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potentiation by cholinoceptor agonists of contractions to field stimulation of rat vas deferens.
    Lee CM
    Br J Pharmacol; 1985 Nov; 86(3):671-6. PubMed ID: 2998523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. (+/-)-Terodiline: an M1-selective muscarinic receptor antagonist. In vivo effects at muscarinic receptors mediating urinary bladder contraction, mydriasis and salivary secretion.
    Noronha-Blob L; Prosser JC; Sturm BL; Lowe VC; Enna SJ
    Eur J Pharmacol; 1991 Aug; 201(2-3):135-42. PubMed ID: 1724648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of the muscarinic receptors in the postsynaptic potentiation of neurogenic twitch contraction in the mouse vas deferens.
    Matsuno K; Mita S
    Life Sci; 1992; 50(11):799-806. PubMed ID: 1740963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of brucine, a plant alkaloid, on M(1) muscarinic receptors and alpha(1)-adrenoceptors in the rabbit vas deferens preparation.
    Bradley KN; Rowan EG; Harvey AL
    Toxicon; 2001 Apr; 39(4):581-7. PubMed ID: 11024498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of the subtype of muscarinic receptor coupled to the stimulation of phosphoinositide hydrolysis in 132-1N1 human astrocytoma cells.
    Stephan CC; Sastry BV
    Cell Mol Biol (Noisy-le-grand); 1992 Nov; 38(7):701-12. PubMed ID: 1282058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of cAMP elevating agents on carbachol-induced phosphoinositide hydrolysis and calcium mobilization in cultured canine tracheal smooth muscle cells.
    Yang CM; Hsu MC; Tsao HL; Chiu CT; Ong R; Hsieh JT; Fan LW
    Cell Calcium; 1996 Mar; 19(3):243-54. PubMed ID: 8732264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sensitization of adenylyl cyclase by P2 purinergic and M5 muscarinic receptor agonists in L cells.
    Johnson JA; Friedman J; Halligan RD; Birnbaumer M; Clark RB
    Mol Pharmacol; 1991 Oct; 40(4):539-46. PubMed ID: 1921986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.